Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Eli Lilly Soars as Alzheimer’s Therapy Gets FDA’s Breakthrough Tag

Stock MarketsJun 24, 2021 17:05
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Dhirendra Tripathi

Investing.com – Eli Lilly (NYSE:LLY) jumped by almost 9% during Thursday’s session as its candidate to treat Alzheimer’s secured breakthrough designation from the Food and Drug Administration.  

The breakthrough tag allows the company to expedite the development of the monoclonal antibody.

Such a designation comes when a company is able to demonstrate that its proposed treatment will bring substantial improvement over already available therapies.

Lilly intends to submit a biologics license application for donanemab under the accelerated approval pathway later this year based on data from the TRAILBLAZER-ALZ study.

The safety, tolerability and efficacy of donanemab are also being evaluated in the ongoing randomized, placebo-controlled, double-blind, multi-center Phase 3 study, Eli Lilly said in a note.

Experts and various other stakeholders were waiting for the outcome of Eli Lilly’s study, particularly after Biogen Inc (NASDAQ:BIIB)’s ADUHELM™ (aducanumab-avwa) became the first Alzheimer’s treatment in 18 years to secure fDA’s accelerated approval.

Alzheimer’s is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually, the ability to carry out simple tasks.

There are currently over 50 million people living with dementia around the world, with numbers expected to increase to nearly 152 million by 2050. Almost 10 million new cases of dementia are diagnosed each year worldwide.

 

Eli Lilly Soars as Alzheimer’s Therapy Gets FDA’s Breakthrough Tag
 

Related Articles

Cadence Design Earnings, Revenue Beat in Q2
Cadence Design Earnings, Revenue Beat in Q2 By Investing.com - Jul 26, 2021

Investing.com - Cadence Design reported on Monday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Cadence Design announced earnings...

Tesla Earnings, Revenue Beat in Q2
Tesla Earnings, Revenue Beat in Q2 By Investing.com - Jul 26, 2021

Investing.com - Tesla reported on Monday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Tesla announced earnings per share of $1.45...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email